Positions

Overview

  • Dr. Velu did his postdoctoral research at the University of Alabama at Tuscaloosa and at Clemson University. He joined the Medicinal Chemistry division of the Center for Biophysical Sciences and Engineering at UAB in 1997 and worked as a Staff Scientist through 2004. He also held a joined appointment in the Chemistry department as a Research Faculty during the period, 2002-2004. He joined the Chemistry department as an Assistant Professor in August of 2004 and was tenured and promoted to Associate Professor Rank in 2010.

    Dr. Velu holds co-appointments as an Associate Scientist at the UAB Comprehensive Cancer Center and the UAB Center for Clinical and Translational Sciences. His teaching responsibilities include both undergraduate and graduate level organic, medicinal and natural product chemistry courses in the department. His research interests are in the areas of organic/medicinal chemistry, drug discovery and development, anti-cancer and anti-infective agents, structure based drug design, in-silico virtual screening, directed combinatorial synthesis, structure activity relationship (SAR) studies, lead optimization, solution phase parallel synthesis, synthesis of marine natural product analogs and development of synthetic methodologies. His research is funded by National Institutes of Health (NIH), American Heart Association (AHA), National Science Foundation (NSF), Susan G. Komen Foundation, Le Studium (France), Alabama Drug Discovery Alliance (ADDA), Comprehensive Cancer Center (CCC), Center for Clinical and Translational Sciences (CCTS) and College of Arts and Sciences (CAS). He serves on the NIH and AHA grant review panels. He serves on the editorial board and edited special issues for the journal Marine Drugs. He has received a National Award for Excellence in Teaching from Center for Educational Policy Research (CEPR), College Board.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53Cancer Letters.  459:156-167. 2019
    2019 A novel marine natural product derived pyrroloiminoquinone with potent activity against skin cancer cellsMarine Drugs.  17. 2019
    2018 Biochemical and epigenetic insights into L-2-hydroxyglutarate, a potential therapeutic target in renal cancerClinical Cancer Research.  24:6433-6446. 2018
    2018 Discovery and characterization of dual inhibitors of MDM2 and NFAT1 for pancreatic cancer therapyCancer Research.  78:5656-5667. 2018
    2018 Inhibition of Streptococcus mutans Biofilms by the Natural Stilbene Piceatannol Through the Inhibition of GlucosyltransferasesACS Omega.  3:8378-8385. 2018
    2018 Discovery and evaluation of nNav1.5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cellsBioorganic and Medicinal Chemistry.  26:2428-2436. 2018
    2018 An expedient synthesis of murrayaquinone A via a novel oxidative free radical reactionTetrahedron Letters.  59:550-553. 2018
    2017 Structure-Based Discovery of Small Molecule Inhibitors of Cariogenic VirulenceScientific Reports.  7. 2017
    2017 Highly efficient delivery of potent anticancer iminoquinone derivative by multilayer hydrogel cubesActa Biomaterialia.  58:386-398. 2017
    2016 Mitochondrial thiol modification by a targeted electrophile inhibits metabolism in breast adenocarcinoma cells by inhibiting enzyme activity and protein levelsRedox Biology.  8:136-148. 2016
    2016 Discovery and development of synthetic tricyclic pyrroloquinone (TPQ) alkaloid analogs for human cancer therapyFrontiers of Chemical Science and Engineering.  10:1-15. 2016
    2016 Channel gating regulation by the cystic fibrosis transmembrane conductance regulator (CFTR) first cytosolic loopJournal of Biological Chemistry.  291:1854-1865. 2016
    2016 Cyanobacterial metabolite calothrixins: Recent advances in synthesis and biological evaluationMarine Drugs.  14. 2016
    2016 Hydroxychalcone inhibitors of Streptococcus mutans glucosyl transferases and biofilms as potential anticaries agentsBioorganic and Medicinal Chemistry Letters.  26:3508-3513. 2016
    2016 Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivoOncotarget.  7:87373-87389. 2016
    2015 Recent advances in isolation, synthesis, and evaluation of bioactivities of bispyrroloquinone alkaloids of marine originChinese Journal of Natural Medicines.  13:561-577. 2015
    2015 New small-molecule inhibitors of dihydrofolate reductase inhibit Streptococcus mutansInternational Journal of Antimicrobial Agents.  46:174-182. 2015
    2015 Development and validation of an HPLC-MS/MS analytical method for quantitative analysis of TCBA-TPQ, a novel anticancer makaluvamine analog, and application in a pharmacokinetic study in ratsChinese Journal of Natural Medicines.  13:554-560. 2015
    2015 A novel class of mitochondria-targeted soft electrophiles modifies mitochondrial proteins and inhibits mitochondrial metabolism in breast cancer cells through redox mechanismsPLoS ONE.  10. 2015
    2015 Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptorOncotarget.  6:21268-21282. 2015
    2014 Total synthesis of calothrixins A and B via oxidative radical reaction of cyclohexenone with aminophenanthridinedioneTetrahedron.  70:5928-5933. 2014
    2014 Antibacterial and Antibiofilm Activities of Makaluvamine Analogs.Microorganisms.  2:128-139. 2014
    2014 L-2-hydroxyglutarate: An epigenetic modifier and putative oncometabolite in renal cancerCancer Discovery.  4:1290-1298. 2014
    2013 Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQCurrent Cancer Drug Targets.  13:651-660. 2013
    2013 Mini-review: Bmx kinase inhibitors for cancer therapyRecent Patents on Anti-Cancer Drug Discovery.  8:228-238. 2013
    2013 Synthesis of pyrroloquinones via a CAN mediated oxidative free radical reaction of 1,3-dicarbonyl compounds with aminoquinonesJournal of Chemistry2013
    2013 Total synthesis of zyzzyanones A-DTetrahedron.  69:4105-4113. 2013
    2013 Erratum: Elevated levels of NO are localized to distal airways in asthma (Free Radical Biology and Medicine (2011) 50 (1679-1688))Free Radical Biology and Medicine.  58:45. 2013
    2013 Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense SuppressionPLoS ONE.  8. 2013
    2012 Anticancer activity and molecular mechanisms of action of makaluvamines and analoguesMolecular and Cellular Pharmacology.  4:69-81. 2012
    2012 Preclinical evaluation of anticancer efficacy and pharmacological properties of FBA-TPQ, a novel synthetic makaluvamine analogMarine Drugs.  10:1138-1155. 2012
    2011 Elevated levels of NO are localized to distal airways in asthmaFree Radical Biology and Medicine.  50:1679-1688. 2011
    2011 Development and validation of an HPLC method for quantitation of BA-TPQ, a novel iminoquinone anticancer agent, and an initial pharmacokinetic study in miceBiomedical Chromatography.  25:628-634. 2011
    2011 Experimental therapy of ovarian cancer with synthetic makaluvamine analog: In Vitro and In Vivo anticancer activity and molecular mechanisms of actionPLoS ONE.  6. 2011
    2010 A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: In vitro and in vivo activity and mechanisms of actionBreast Cancer Research and Treatment.  123:321-331. 2010
    2010 Synthesis and structure activity relationship studies of novel Staphylococcus aureus Sortase A inhibitorsChimica therapeutica.  45:3752-3761. 2010
    2010 Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agentMarine Drugs.  8:2129-2141. 2010
    2010 FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancerInvestigational New Drugs.  28:234-241. 2010
    2010 Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductaseBioorganic and Medicinal Chemistry.  18:4056-4066. 2010
    2009 Synthesis and the crystal structure of (E)-2-(7-(3-(Thiophen-2-yl) acrylamido)-2,3-dihydro-5-oxobenzo[e][1,4]oxazepin-1(5H)-yl)ethyl acetateJournal of Chemical Crystallography.  39:902-907. 2009
    2009 Synthesis and in vitro anti-lung cancer activity of novel 1, 3, 4, 8-tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-o ne alkaloid analogsMedicinal Chemistry.  5:227-236. 2009
    2009 A facile synthesis of bispyrroloquinone and bispyrroloiminoquinone ring system of marine alkaloidsTetrahedron Letters.  50:3074-3076. 2009
    2009 Synthesis of biotin-tagged chemical cross-linkers and their applications for mass spectrometryRapid Communications in Mass Spectrometry.  23:1719-1726. 2009
    2009 In vitro and in vivo anticancer activity of novel synthetic makaluvamine analoguesClinical Cancer Research.  15:3511-3518. 2009
    2008 Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase functionProteins.  73:889-901. 2008
    2008 Azide-mediated detosylation of N-tosylpyrroloiminoquinones and N-tosylindole-4,7-quinonesSYNLETT.  2864-2868. 2008
    2008 Synthesis and antiproliferative activity of benzyl and phenethyl analogs of makaluvaminesBioorganic and Medicinal Chemistry.  16:2541-2549. 2008
    2008 Synthesis of E isomer and crystal structures of E and Z isomers of 3-(2,5-dimethoxyphenyl)-2-(4-methoxyphenyl)acrylonitrileJournal of Chemical Crystallography.  38:205-209. 2008
    2008 Synthesis, separation and crystal structures of E and Z isomers of 3-(2,5-dimethoxyphenyl)-2-(4-methoxyphenyl)acrylic acidJournal of Chemical Crystallography.  38:189-194. 2008
    2008 Identification of novel inhibitors of bacterial surface enzyme Staphylococcus aureus Sortase ABioorganic and Medicinal Chemistry Letters.  18:380-385. 2008
    2007 Antibacterial nicotinamide adenine dinucleotide synthetase inhibitors: Amide- and ether-linked tethered dimers with α-amino acid end groupsJournal of Medicinal Chemistry.  50:2612-2621. 2007
    2007 Analogs of the marine alkaloid makaluvamines: Synthesis, topoisomerase II inhibition, and anticancer activityBioorganic and Medicinal Chemistry Letters.  17:2890-2893. 2007
    2007 Total synthesis of secobatzelline BSynthetic Communications.  37:2399-2409. 2007
    2005 Tethered dimer inhibitors of NAD synthetase: Parallel synthesis of an aryl-substituted SAR libraryJournal of Combinatorial Chemistry.  7:898-904. 2005
    2001 Design, synthesis, and biological activity of a new class of tethered dimers as inhibitors of NAD synthetase.ACS National Meeting Book of Abstracts.  222:U687-U687. 2001
    2000 Erratum: Oxidative steam reforming of methanol over CuZnAl(Zr)-oxide catalyst; a new and efficient method for the production of CO-free hydrogen for fuel cells (Chemical Communications (1999) 2341))Chemical Communications.  249. 2000
    1997 (α-Aminoalkyl)cuprates Prepared from Soluble Copper(I) Salts: Conjugate Additions to α,βUnsaturated Carboxylic Acid DerivativesJournal of Organic Chemistry.  62:3798-3799. 1997
    1997 Regioselective Control in the Reactions of α-Aminoalkylcuprates with Allylic SubstratesSYNLETT.  1997:1114-1116. 1997
    1996 Oxidation of α,β-enones and alkenes with oxone and sodium halides: A convenient laboratory preparation of chlorine and bromineTetrahedron Letters.  37:2377-2380. 1996
    1995 Regioselective Animation of Indole-4,7-quinonesJournal of Organic Chemistry.  60:3543-3545. 1995
    1995 Efficient Syntheses of the Marine Alkaloiss Makaluvamine D and Discorhabdnn C: The 4,6,7-Trimethoxyindole ApproachJournal of Organic Chemistry.  60:1800-1805. 1995
    1994 A Novel o-Quinodimethane Tandem Diels-Alder ReactionJournal of Organic Chemistry.  59:4308-4310. 1994
    1993 Total syntheses of damirone A and damirone BTetrahedron Letters.  34:2405-2408. 1993
    1992 Synthesis of 2-alkylindoles via sulfonesSYNTHESIS.  648-650. 1992

    Research Overview

  • The main focus of Dr. Velu’s lab is drug discovery and development. Lab work force is mainly constituted of graduate students working towards their PhD degree, undergraduate students carrying out their senior / honors research, postdoctoral trainees and occasionally research assistants. The research projects are mainly directed towards the discovery of anti-cancer and anti-infective agents. His research is funded by National Institutes of Health (NIH), American Heart Association (AHA), National Science Foundation (NSF), Susan G. Komen Foundation, Le Studium (France), Alabama Drug Discovery Alliance (ADDA), Comprehensive Cancer Center (CCC), Center for Clinical and Translational Sciences (CCTS) and College of Arts and Sciences (CAS).The ongoing research projects are:

    Marine Alkaloid Analogs for Breast Cancer Therapy
    In spite of the recent advances in computational approaches for lead identification and drug discovery, natural products remain as an important source for novel anticancer agents. In addition, natural products provide drugs with unprecedented molecular structures and bioactivity that are often inaccessible by other methods, and provide templates for future drug design. Our laboratory has focused recent research on the development of novel marine natural products and their analogs for human breast cancer therapy.

    Staphylococcus aureus Sortase A inhibitors
    As bacterial pathogens develop resistance to conventional antibiotics, inhibition of bacterial surface protein display offers a novel strategy against S. aureus bacterial infections. By interrupting bacterial adherence, the initial step in the pathogenesis of bacterial infections, S. aureus will be poorly equipped to cause the disease and may be more effectively cleared by host innate immune defenses and/or by antibiotics. We hypothesize that the inhibitors of the surface enzyme, sortase will render S. aureus non-adherent and consequently less virulent.

    Voltage Gated Sodium Channel Blockers
    The ability to prevent or slow down metastasis would represent a major breakthrough in cancer therapy and dramatically improve life expectancies of cancer patients. Fortunately, our increasing understanding of the metastatic process has recently resulted in the discovery of new potential drug targets to prevent / slow metastasis. One such target is the voltage-Gated Sodium Channels (VGSC). This project is directed towards targeting VGSCs for developing drugs that prevent / slow down breast and prostate cancer metastasis.

    Trypanosoma Cruzi DHFR inhibitors
    Chagas disease is caused by the protozoan parasite Trypanosoma cruzi (T. cruzi). Since the dihydrofolate reductase (DHFR) activity of T. cruzi (TcDHFR) is essential for the parasite, it represents a potential target for the rational drug design for Chagas disease. In order to facilitate the design of selective inhibitors of TcDHFR we have initiated a structure based drug design using the X-ray crystal structure of T. cruzi DHFR. Subtle differences in the active sites of TcDHFR and hDHFR are taken in to consideration in order to design more selective and potent inhibitors of TcDHFR.
  • Teaching Overview

  • Dr. Velu teaches both undergraduate and graduate level courses in the Chemistry department of UAB. The main focus of his teaching is in the areas of Organic Chemistry, Natural Products, Medicinal Chemistry and Drug Discovery. His Organic Chemistry course was identified as an example of Best Practices in a National Study of Chemistry courses conducted by the Center for Educational Policy Research (CEPR) on behalf of the College Board. A total of 166 courses from across the nation were reviewed in this study.

    The following is the listing of all courses currently offered by Dr. Velu.​

    Undergraduate Courses
    CH 235: Organic Chemistry I.
    CH 237: Organic Chemistry II.
    CH 472: Chemistry of Natural Products.
    CH 497: Undergraduate Research.
    CH 499: Honors Research and Thesis.

    Graduate Courses
    CH 701: Foundations of Organic and Inorganic Chemistry.
    CH 772: Chemistry of Natural Products.
    CH 732: Organic Reactions and Synthesis.
    IBS 708: Modern Drug Design and Development (Team Taught).
    CH 798: Non-Dissertation Research.
    CH 799: Dissertation Research.
  • Teaching Activities

  • CH732 - Organic Reaction and Synthesis (Fall Term 2019) 2019
  • CH798 - Non-Dissertation Research (Fall Term 2019) 2019
  • CH798 - Non-Dissertation Research (Summer Term 2019) 2019
  • CH472 - Chemistry of Natural Products (Spring Term 2019) 2019
  • CH772 - Chemistry of Natural Products (Spring Term 2019) 2019
  • CH798 - Non-Dissertation Research (Spring Term 2019) 2019
  • CH732 - Organic Reaction and Synthesis (Fall Term 2018) 2018
  • CH798 - Non-Dissertation Research (Fall Term 2018) 2018
  • CH235 - Organic Chemistry I (Summer Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Summer Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Summer Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Summer Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Summer Term 2018) 2018
  • CH798 - Non-Dissertation Research (Summer Term 2018) 2018
  • CH235 - Organic Chemistry I (Spring Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Spring Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Spring Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Spring Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Spring Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Spring Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Spring Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Spring Term 2018) 2018
  • CH235R - Organic Chemistry I Recitation (Spring Term 2018) 2018
  • CH798 - Non-Dissertation Research (Spring Term 2018) 2018
  • CH237 - Organic Chemistry II (Fall Term 2017) 2017
  • CH237R - Organic Chem II Recitation (Fall Term 2017) 2017
  • CH237R - Organic Chem II Recitation (Fall Term 2017) 2017
  • CH237R - Organic Chem II Recitation (Fall Term 2017) 2017
  • CH237R - Organic Chem II Recitation (Fall Term 2017) 2017
  • CH237R - Organic Chem II Recitation (Fall Term 2017) 2017
  • CH237R - Organic Chem II Recitation (Fall Term 2017) 2017
  • CH798 - Non-Dissertation Research (Fall Term 2017) 2017
  • CH235 - Organic Chemistry I (Summer Term 2017) 2017
  • CH235R - Organic Chemistry I Recitation (Summer Term 2017) 2017
  • CH235R - Organic Chemistry I Recitation (Summer Term 2017) 2017
  • CH235R - Organic Chemistry I Recitation (Summer Term 2017) 2017
  • CH798 - Non-Dissertation Research (Summer Term 2017) 2017
  • CH235 - Organic Chemistry I (Spring Term 2017) 2017
  • CH235R - Organic Chemistry I Recitation (Spring Term 2017) 2017
  • CH235R - Organic Chemistry I Recitation (Spring Term 2017) 2017
  • CH235R - Organic Chemistry I Recitation (Spring Term 2017) 2017
  • CH235R - Organic Chemistry I Recitation (Spring Term 2017) 2017
  • CH235R - Organic Chemistry I Recitation (Spring Term 2017) 2017
  • CH235R - Organic Chemistry I Recitation (Spring Term 2017) 2017
  • CH798 - Non-Dissertation Research (Spring Term 2017) 2017
  • CH799 - Dissertation Research (Spring Term 2017) 2017
  • CH237 - Organic Chemistry II (Fall Term 2016) 2016
  • CH237R - Organic Chem II Recitation (Fall Term 2016) 2016
  • CH237R - Organic Chem II Recitation (Fall Term 2016) 2016
  • CH237R - Organic Chem II Recitation (Fall Term 2016) 2016
  • CH237R - Organic Chem II Recitation (Fall Term 2016) 2016
  • CH237R - Organic Chem II Recitation (Fall Term 2016) 2016
  • CH237R - Organic Chem II Recitation (Fall Term 2016) 2016
  • CH701 - Foundations of Org/Inorg Chem (Fall Term 2016) 2016
  • CH798 - Non-Dissertation Research (Fall Term 2016) 2016
  • CH799 - Dissertation Research (Fall Term 2016) 2016
  • CH235 - Organic Chemistry I (Summer Term 2016) 2016
  • CH235R - Organic Chemistry I Recitation (Summer Term 2016) 2016
  • CH235R - Organic Chemistry I Recitation (Summer Term 2016) 2016
  • CH235R - Organic Chemistry I Recitation (Summer Term 2016) 2016
  • CH799 - Dissertation Research (Summer Term 2016) 2016
  • CH798 - Non-Dissertation Research (Summer Term 2016) 2016
  • CH235 - Organic Chemistry I (Spring Term 2016) 2016
  • CH235R - Organic Chemistry I Recitation (Spring Term 2016) 2016
  • CH235R - Organic Chemistry I Recitation (Spring Term 2016) 2016
  • CH235R - Organic Chemistry I Recitation (Spring Term 2016) 2016
  • CH235R - Organic Chemistry I Recitation (Spring Term 2016) 2016
  • CH235R - Organic Chemistry I Recitation (Spring Term 2016) 2016
  • CH235R - Organic Chemistry I Recitation (Spring Term 2016) 2016
  • CH798 - Non-Dissertation Research (Spring Term 2016) 2016
  • CH799 - Dissertation Research (Spring Term 2016) 2016
  • CH235 - Organic Chemistry I (Fall Term 2015) 2015
  • CH701 - Foundations of Org/Inorg Chem (Fall Term 2015) 2015
  • CH732 - Organic Reaction and Synthesis (Summer Term 2015) 2015
  • CH235 - Organic Chemistry I (Spring Term 2015) 2015
  • CH235R - Organic Chemistry I Recitation (Spring Term 2015) 2015
  • CH235R - Organic Chemistry I Recitation (Spring Term 2015) 2015
  • CH235R - Organic Chemistry I Recitation (Spring Term 2015) 2015
  • CH235R - Organic Chemistry I Recitation (Spring Term 2015) 2015
  • CH235R - Organic Chemistry I Recitation (Spring Term 2015) 2015
  • CH235R - Organic Chemistry I Recitation (Spring Term 2015) 2015
  • CH235 - Organic Chemistry I (Fall Term 2014) 2014
  • CH701 - Foundations of Org/Inorg Chem (Fall Term 2014) 2014
  • CH235 - Organic Chemistry I (Summer Term 2014) 2014
  • CH235R - Organic Chemistry I Recitation (Summer Term 2014) 2014
  • CH235R - Organic Chemistry I Recitation (Summer Term 2014) 2014
  • CH235R - Organic Chemistry I Recitation (Summer Term 2014) 2014
  • CH472 - Chemistry of Natural Products (Spring Term 2014) 2014
  • CH772 - Chemistry of Natural Products (Spring Term 2014) 2014
  • CH237 - Organic Chemistry II (Fall Term 2013) 2013
  • CH237R - Organic Chem II Recitation (Fall Term 2013) 2013
  • CH237R - Organic Chem II Recitation (Fall Term 2013) 2013
  • CH237R - Organic Chem II Recitation (Fall Term 2013) 2013
  • CH237R - Organic Chem II Recitation (Fall Term 2013) 2013
  • CH237R - Organic Chem II Recitation (Fall Term 2013) 2013
  • CH701 - Foundations of Org/Inorg Chem (Fall Term 2013) 2013
  • CH732 - Organic Reaction and Synthesis (Summer Term 2013) 2013
  • CH235 - Organic Chemistry I (Spring Term 2013) 2013
  • CH235R - Organic Chemistry I Recitation (Spring Term 2013) 2013
  • CH235R - Organic Chemistry I Recitation (Spring Term 2013) 2013
  • CH235R - Organic Chemistry I Recitation (Spring Term 2013) 2013
  • CH235R - Organic Chemistry I Recitation (Spring Term 2013) 2013
  • CH235R - Organic Chemistry I Recitation (Spring Term 2013) 2013
  • CH235R - Organic Chemistry I Recitation (Spring Term 2013) 2013
  • CH535 - Organic Chem I for Grad Study (Spring Term 2013) 2013
  • CH237 - Organic Chemistry II (Fall Term 2012) 2012
  • CH237R - Organic Chem II Recitation (Fall Term 2012) 2012
  • CH237R - Organic Chem II Recitation (Fall Term 2012) 2012
  • CH237R - Organic Chem II Recitation (Fall Term 2012) 2012
  • CH237R - Organic Chem II Recitation (Fall Term 2012) 2012
  • CH701 - Foundations of Org/Inorg Chem (Fall Term 2012) 2012
  • CH235 - Organic Chemistry I (Summer Term 2012) 2012
  • CH235R - Organic Chemistry I Recitation (Summer Term 2012) 2012
  • CH235R - Organic Chemistry I Recitation (Summer Term 2012) 2012
  • CH235R - Organic Chemistry I Recitation (Summer Term 2012) 2012
  • CH237 - Organic Chemistry II (Spring Term 2012) 2012
  • CH537 - Organic Chem II for Grad Study (Spring Term 2012) 2012
  • CH772 - Chemistry of Natural Products (Spring Term 2012) 2012
  • CH235 - Organic Chemistry I (Fall Term 2011) 2011
  • CH701 - Foundations of Org/Inorg Chem (Fall Term 2011) 2011
  • CH237 - Organic Chemistry II (Summer Term 2011) 2011
  • CH237R - Organic Chem II Recitation (Summer Term 2011) 2011
  • CH237R - Organic Chem II Recitation (Summer Term 2011) 2011
  • CH237R - Organic Chem II Recitation (Summer Term 2011) 2011
  • CH472 - Chemistry of Natural Products (Spring Term 2011) 2011
  • CH772 - Chemistry of Natural Products (Spring Term 2011) 2011
  • CH235 - Organic Chemistry I (Fall Term 2010) 2010
  • CH701 - Foundations of Org/Inorg Chem (Fall Term 2010) 2010
  • CH237 - Organic Chemistry II (Summer Term 2010) 2010
  • CH237R - Organic Chem II Recitation (Summer Term 2010) 2010
  • CH237R - Organic Chem II Recitation (Summer Term 2010) 2010
  • CH237R - Organic Chem II Recitation (Summer Term 2010) 2010
  • CH237 - Organic Chemistry II (Spring Term 2010) 2010
  • CH235 - Organic Chemistry I (Fall Term 2009) 2009
  • CH235 - Organic Chemistry I (Summer Term 2009) 2009
  • CH235R - Organic Chemistry I Recitation (Summer Term 2009) 2009
  • CH235R - Organic Chemistry I Recitation (Summer Term 2009) 2009
  • CH235R - Organic Chemistry I Recitation (Summer Term 2009) 2009
  • CH472 - Chemistry of Natural Products (Spring Term 2009) 2009
  • CH672 - Chemistry of Natural Products (Spring Term 2009) 2009
  • CH772 - Chemistry of Natural Products (Spring Term 2009) 2009
  • CH237 - Organic Chemistry II (Fall Term 2008) 2008
  • CH701 - Foundations of Org/Inorg Chem (Fall Term 2008) 2008
  • CH237 - Organic Chemistry II (Summer Term 2008) 2008
  • CH235 - Organic Chemistry I (Spring Term 2008) 2008
  • CH237 - Organic Chemistry II (Fall Term 2007) 2007
  • Education And Training

  • Clemson University, Other 1997
  • Doctor of Philosophy in Organic Chemistry, University of Madras 1993
  • University of Alabama, Tuscaloosa, Postdoctoral Fellowship 1994
  • Full Name

  • Sadanandan Velu